The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
November 2003 Michael R. Taylor, Margaret O'K. Glavin, J. Glenn Morris, Jr., and Catherine E. Woteki; Co-published with Resources for the Future,
August 2019 Matthew Herder ,
Despite loosening its standards for drug approval over time, the US Food and Drug Administration (FDA) is not restructuring itself to properly enforce the ongoing regulation of drugs once they are on the market. Current and former FDA officials interviewed for this study affirmed the FDA also has little legal authority to oversee postmarket studies. More
July 2019 Audrey D. Zhang , Jason L. Schwartz , Joseph S. Ross ,
The FDA disagreed with 22% of its advisory committee recommendations over an 8-year period, according to this original research. In the case of disagreements, the FDA tended to be less likely than its advisory committees to approve new products, approve new supplemental indications, or enact new safety changes. More
April 2018 Joshua M. Sharfstein ,
On the day after the horrific shooting that claimed the lives of 17 students at Stoneman Douglas High School in Parkland, Florida, the local state… More
June 2010 Milbank Memorial Fund ,
Scott Burris, a graduate of Yale Law School, is a professor at Temple University Beasley School of Law and director of the National Program… More
Primary Care Transformation Total Costs of Care State Health Policy Leadership
March 2020 Victoria Veltri ,
In January, Connecticut Governor Ned Lamont issued an executive order that requires the state to develop an annual health care cost growth benchmark,… More
February 2020 Paula M. Lantz ,
Lantz argues that super-utilizer interventions are cost-containment strategies that can help patients who are in critical need. To address its fundamental problems, the US needs broader solutions that are “aimed at the macro- and community-level systems and institutions that drive social, political, and economic disadvantage and health inequities.” More
State Health Policy Leadership
October 2019 Jennifer Lee ,
New research published in “The Milbank Quarterly” that finds Medicaid block grants could lead community health centers lose over $7 billion by 2024 should give pause to supporters of block grants, says former director of the Virginia Department of Medical Assistance Services Jennifer Lee, MD, in a Milbank blog post. More
October 2019 Brian J. Miller , Gail R. Wilensky ,
To contain the prices of high-cost biologics, Miller and Wilensky propose use of either a reference price—based on “standard of care therapy” as opposed to an international pricing index—or abbreviated exclusivity for drugs approved via the accelerated pathway. More
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, historical, legal, and ethical dimensions of health and health care policy.